In this second-part of a two-part interview piece, Koen Cobbaert, senior manager, quality, standards and regulations, at Royal Philips looks in more detail at the impossible situation that notified bodies could find themselves in due to the new AI Act, at how it will impact IVDs in particular, and at the very important, but potentially compromised, issue of standards.
Koen Cobbaert






